$ALKT Balance Sheet | Understand Stock

$ALKT

$15.36 -$0.35 (2.23%) Close

$ALKT Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD; shares in millions, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Assets
Current assets
Cash and cash equivalents
Marketable securities
Accounts receivable, net
Deferred implementation costs, current
Deferred costs, current
Prepaid expenses and other current assets
Total current assets

Property and equipment, net
Deferred implementation costs, net of current portion
Right-of-use assets
Deferred costs, net of current portion
Intangibles, net
Goodwill
Other assets
Total assets

Liabilities and Stockholders' Equity
Current liabilities
Current portion of long-term debt
Accounts payable
Accrued liabilities
Deferred rent and tenant allowance, current portion
Deferred revenues, current portion
Lease liabilities, current portion
Total current liabilities

Long-term debt, net
Warrant liability
Deferred revenues, net of current portion
Deferred rent and tenant allowance, net of current portion
Deferred income taxes
Convertible senior notes, net
Revolving loan
Lease liabilities, net of current portion
Other non-current liabilities
Total liabilities
Redeemable convertible preferred stock, $0.001 par value, 0 and 72,799,602 shares authorized and 0 and 72,225,916 shares issued and outstanding as of December 31, 2021 and 2020, respectively
Stockholders’ Equity
Preferred stock, $0.001 par value, 10,000,000 shares authorized and 0 shares issued and outstanding as of June 30, 2026 and December 31, 2025
Common stock, $0.001 par value, 500,000,000 and 101,671,156 shares authorized and 89,954,657 and 4,909,529 shares issued and outstanding as of December 31, 2021 and 2020, respectively
Common stock, $0.001 par value, 500,000,000 shares authorized; and 106,941,980 and 106,101,875 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital
Accumulated deficit
Total stockholders’ equity

Total liabilities and stockholders' equity

Preferred Stock, Shares Authorized
Preferred Stock, Shares Outstanding
Preferred stock, issued (in shares)
Common stock, shares authorized (in shares)

Comments